EL7.AI
StocksMediumUpdated×3•Originally published 29 October 2026•Updated 30 October 2026•
3 min read

Alignment Healthcare Membership Jumps 31.2% to 301,200 as It Swings to $8.052 Million Loss

Key Facts

1Health plan membership reached about 301,200 at the end of the third quarter, up 31.2% year over year.
2The company posted a net loss of $8.052 million, compared with net income of $3.729 million a year earlier.
3The medical benefit ratio was 89.5%, up about 240 basis points year over year.
4The company set a 2026 revenue floor of $5,245 million and adjusted earnings before interest, taxes, depreciation and amortization of at least $100 million.

Alignment Healthcare posted a net loss of $8.052 million in the third quarter of 2026, compared with net income of $3.729 million in the same period a year earlier, as membership in its health plans reached about 301,200, up 31.2% year over year. The company said in results released on October 29 that medical care costs were higher than expected in the quarter ended September 30. Diluted loss per share was $0.04, compared with earnings of $0.02 a year earlier. Revenue, meanwhile, topped analyst estimates, while the per-share loss matched expectations. Chief Executive John Kao said “medical cost trends came in higher than expected,” adding that the company is taking a cautious approach to the final quarter of the year.

Adjusted gross profit was $142.2 million, up 11.6% from the third quarter of last year, but the company swung from operating income of $7.681 million to an operating loss of $3.794 million. Adjusted earnings before interest, taxes, depreciation and amortization were $21.8 million, equivalent to a margin of 1.6%, down 32.8% year over year. The indicators show activity expanding alongside a contraction in operating profitability. The medical benefit ratio, calculated on an adjusted gross profit basis, was 89.5%, up about 240 basis points annually. The company said the ratio was affected by seasonality in Part D and the timing of clinical investments, as well as higher costs for appeals and disputes, catastrophic cases and skilled nursing facilities.

Management attributed the profitability outlook revision to the higher medical costs recorded during the third quarter, while pointing to continued sales momentum. The company said it raised its full-year membership and revenue outlook while lowering its forecasts for adjusted gross profit and adjusted earnings before interest, taxes, depreciation and amortization. For fiscal 2026, it set a floor of 305,000 members and revenue of $5,245 million. It also set minimums of $575 million for adjusted gross profit and $100 million for adjusted earnings before interest, taxes, depreciation and amortization. Kao said the company is “taking a cautious approach to the fourth quarter and lowering our outlook based on current pressures.”

For the fourth quarter, the company expects membership of at least 305,000 and revenue of at least $1,316 million, along with adjusted gross profit of at least $104 million. It set guidance for adjusted earnings before interest, taxes, depreciation and amortization at negative $28 million, a negative estimate for the period. Analysts estimate quarterly revenue at $1.33 billion, compared with the company’s guidance of $1.32 billion; their average for the year is $5.22 billion, compared with the company’s guidance of $5.25 billion. Third-quarter revenue topped analysts’ estimate of $1.31 billion, while the per-share loss matched their estimate of $0.04. The company held its results discussion call on October 29 at 5:00 p.m. Eastern Time.

The results come as the Centers for Medicare & Medicaid Services projected that final policies would raise Medicare Advantage plan payments by 2.48%, or more than $13 billion, in 2027. The centers had projected a 5.06% increase in payments in 2026. For the stock, EL7 data showed a close of $8.18 on October 28, the eve of the results announcement, and then $8.06 on October 29. The open Investing.com report did not provide an after-hours trading price or percentage; it said fourth-quarter revenue guidance came in below the analyst average. These figures keep care-cost pressures and revenue expectations at the center of investors’ focus on upcoming results.

Open on chart